Cure My Disease

Don't miss your cure!

 Log in / Sign up

Polish breast cancer treatment patterns revealed in new study

NCT ID NCT05478590

Completed Knowledge-focused Sponsor: Pfizer Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study observed 440 adults in Poland with advanced HR+ HER2- breast cancer to understand how doctors treat the disease in everyday practice. Researchers tracked treatment choices, changes over one year, and how they relate to patient characteristics and guidelines. The goal was to gather real-world data, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast neoplasm hormone receptor-positive breast cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST NEOPLASMS

Contacts and locations

Locations

  • Ambulatorium Chemioterapii Centrum Onkologii

    Bydgoszcz, 85-796, Poland

  • Centralny Szpital Kliniczny MSWiA w Warszawie

    Warsaw, 02-507, Poland

  • Dolnośląskie Centrum Onkologii

    Wroclaw, 53-413, Poland

  • Izerskie Centrum Pulmonologii i Chemioterapii "Izer-Med" Sp. z o.o

    Szklarska Poręba, 58-580, Poland

  • Klinika Onkologii, Instytut Centrum Zdrowia Matki Polki

    Lodz, 93-338, Poland

  • Narodowy Instytut Onkologii

    Krakow, 31-115, Poland

  • Oddział Onkologii Klinicznej

    Kalisz, 62-800, Poland

  • Oddział Onkologii Klinicznej z Pododdziałem Dziennym

    Krakow, 31-816, Poland

  • Oddział onkologii Szpital Specjalistyczny im. H. Klimontowicza

    Gorlice, 38-300, Poland

  • Oddział/Poradnia Onkologiczna Wojewodzki Szpital w Przemyślu

    Przemyśl, 37-700, Poland

  • Opolskie Centrum Onkologii

    Opole, 45-061, Poland

  • Pfizer Polska

    Warsaw, Poland

  • Podkarpackie Centrum Onkologii

    Rzeszów, 35-055, Poland

  • SPZOZ Oddział onkologii klinicznej

    Swidnica, 58-100, Poland

  • Specjalistyczny Szpital Onkologiczny NU-MED

    Tomaszów Mazowiecki, 92-700, Poland

  • Uniwersyteckie Centrum Kliniczne, Klinika Onkologii i Radioterapii

    Gdansk, 80-214, Poland

  • Wojewodzki Szpital Specjalistyczny we Wroclawiu

    Wroclaw, 51-124, Poland

  • Wojewodzki Szpital Zespolony w Elblągu - oddzial onkologii

    Elblag, 82-300, Poland

  • Zachodniopomorskie Centrum Onkologii

    Szczecin, 71-730, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.